Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.

CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...

When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms ...

Citation: New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions' (2023, November 20) retrieved 5 December 2023 from https://medicalxpress.com ...

Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.

Dec. 4, 2023 — A study suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive ... Researchers Develop New Brain ...

According to the Centers for Disease Control and Prevention, Alzheimer's is the seventh leading cause of death in Ohio, which recorded a 34.2% Alzheimer's mortality rate in 2021 with 4,947 deaths ...

This study tried to detect any molecular substrate that might be shared by brain disorders in general, comparing gene expression profiles across multiple brain areas determined by post-mortem ...

Nov. 20—(StatePoint) 2023 was a landmark year for Alzheimer's disease research, including advancements in treatment, risk factors and diagnosis. Here are five significant discoveries made this year: ...

CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...